| Trial ID: | L0624 |
| Source ID: | NCT02234440
|
| Associated Drug: |
Metformin
|
| Title: |
Effect of Metformin on Disease Progression in Patients With Cryptogenic Cirrhosis (NASH-related Cirrhosis) With Diabetes or Impaired Glucose Tolerance or Insulin Resistance: a Prospective Randomized, Open Labeled, Clinical Trial"
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
NASH Related Cirrhosis
|
| Interventions: |
Drug: Metformin;Drug: Insulin
|
| Outcome Measures: |
Reduction of portal pressureImprovement in fibrosis(assessed by noninvasive methods like Fibroscan and Fib 4 index);Safety profile of the drugs like Random Blood Sugar (RBS) and serum lactate monitoring regularly.
|
| Sponsor/Collaborators: |
Institute of Liver and Biliary Sciences, India
|
| Gender: |
All
|
| Age: |
18 Yearsnan
|
| Phases: |
Not applicable
|
| Enrollment: |
86
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
| Start Date: |
31/08/2014
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
India
|
| URL: |
https://clinicaltrials.gov/show/NCT02234440
|
